Brain Neoplasms: all 1,993 studies
Page 10 of 20. Open to participants first (516), then studies with results posted, then the rest; newest registration first within each.
- Comparing Single vs Multiple Dose Radiation for Cancer Patients With Brain Metastasis and Receiving ImmunotherapyActive, not recruitingNCT05703269Not applicable
- AssesSment of Early deteCtion basEd oN liquiD Biopsy in Intracranial TumorsStatus unknownNCT05679089
- Real-World Assessment of Clinical Outcomes in Metastatic NSCLC Patients With MET Exon 14 Skipping Mutation and Brain Metastases Treated With CapmatinibCompletedNCT05675683
- CA-4948 in Combination With Pembrolizumab and Stereotactic Radiosurgery to Improve Treatment of Melanoma Brain MetastasesSuspendedNCT05669352Phase 1/2
- Evaluation of the Contribution of NODDI Protocol Tractography in Brain Tumor SurgeryWithdrawnNCT05669326Not applicable
- A Phase 1b / 2 Drug Resistant Immunotherapy With Activated, Gene Modified Allogeneic or Autologous γδ T Cells (DeltEx) in Combination With Maintenance Temozolomide in Subjects With Recurrent or Newly Diagnosed GlioblastomaActive, not recruitingNCT05664243Phase 1/2
- RNA Lipid Particles Targeting Pediatric Recurrent Intracranial Malignancies and Other systEmic Solid TumorsActive, not recruitingNCT05660408Phase 1/2
- Evaluation of Fluoxetine and Cytotoxic Lysosomal Stress in Glioma (FLIRT)Active, not recruitingNCT05634707Early Phase 1
- Blood Brain Barrier (BBB) Disruption Using Exablate Focused Ultrasound With Doxorubicin for Treatment of Pediatric Diffuse Intrinsic Pontine Gliomas (DIPG)Active, not recruitingNCT05630209Phase 1/2
- ARISTOCRAT: Blinded Trial of Temozolomide +/- CannabinoidsActive, not recruitingNCT05629702Phase 2
- A Window of Opportunity Study of Patritumab Deruxtecan in Patients With Brain MetastasesWithdrawnNCT05620914Phase 2
- Combination of Local Therapy and Target Therapy for Brain Metastases With EGFR MutationStatus unknownNCT05616377
- Blood Brain Barrier (BBB) Disruption Using Exablate Focused Ultrasound With Doxorubicin for Treatment of Pediatric DIPGActive, not recruitingNCT05615623Phase 1/2
- Treatments for Brain Metastases With Poor Prognostic FactorsStatus unknownNCT05609162
- A Phase 1 Trial of ZN-A-1041 Enteric Capsules or Combination in Participants With Human Epidermal Growth Factor Receptor 2 (HER2)-Positive Advanced Solid TumorsActive, not recruitingNCT05593094Phase 1/2
- Forgotten Voices: Addressing Unmet Needs in Brain Tumor CaregiversTerminatedNCT05590273Not applicable
- Dose-escalation by Hypofractionated Stereotactic Radiotherapy for Brain Metastases in Non Small Cell Lung CancerStatus unknownNCT05588206Phase 1/2
- Evaluation of Clinical Decision Support System for Brain Metastasis Using Brain MR ImagesStatus unknownNCT05573815Not applicable
- Central Nervous System Efficacy of Capmatinib in NSCLC With Brain Metastases With cfDNA Positive MET AlterationsWithdrawnNCT05567055Phase 2
- Effects of Two Different Goals of Fluid Management in Patients Undergoing Supratentorial Tumour ResectionStatus unknownNCT05561894Not applicable
- F-Tryptophan PET/CT in Human CancersCompletedNCT05556473Phase 1
- A Virtually Delivered Exercise Intervention To Mitigate Cognitive Deficits From Radiotherapy In AYAs With Brain TumorsTerminatedNCT05554159Not applicable
- Tucatinib, Trastuzumab, and Capecitabine With SRS for Brain Metastases From HER-2 Positive Breast CancerTerminatedNCT05553522Phase 1
- A Study to Learn About the Study Medicine Called PF-07799544 as Monotherapy or in Combination in People With Advanced Solid TumorsActive, not recruitingNCT05538130Phase 1
- Exercise Study in Brain and CNS CancerCompletedNCT05531695Not applicable
- Effects of SMR Neurofeedback on Insomnia in Patients With Benign Brain TumorsTerminatedNCT05518942Not applicable
- Measuring Brain Tumor Consistency Using Magnetic Resonance ElastographyWithdrawnNCT05516485Not applicable
- Neuropsychological Care for Maintaining Quality of Life After Radiation Therapy in Patients With Brain MetastasesCompletedNCT05503251Phase 2
- Functional Navigation in Surgery of Cerebral Tumors and Vascular MalformationsSuspendedNCT05484219Not applicable
- A Study to Assess the Efficacy of Cerebellar IMRT Combined With Cerebral SRS in Patients With Brain MetastasesStatus unknownNCT05477316Not applicable
- Intraoperative Sonographically Versus Fluorescence-guided Resection of Contrast-enhancing Gliomas and Brain MetastasesSuspendedNCT05475522Not applicable
- Furmonertinib in EGFR-Mutant NSCLC With Brain Metastases (iFORCE)CompletedNCT05465343Phase 2
- Efficacy and Safety Evaluation of Percutaneous Ommaya Capsule Injection of Autologous Bi-dimensional Specific T Cells in the Treatment of Glioma and in Combination With Pemetrexed in the Treatment of Brain/Meningeal MetastasesStatus unknownNCT05459441Early Phase 1
- Comparing the Addition of Radiation Either Before or After Surgery for Patients With Brain MetastasesActive, not recruitingNCT05438212Phase 3
- Keto-Brain:Investigating the Use of Ketogenic Diets in Brain MetastasesSuspendedNCT05428852Not applicable
- Simulation Training in Emergency Department Imaging 2CompletedNCT05427838Not applicable
- Imaging Study on Halcyon 4.0 System for Patients Receiving Radiation TherapyCompletedNCT05427214Not applicable
- Interest of a Weekly Consultation by a Medical Electro Radiology Manipulator (MERM) in Addition to the Follow-up by the Radiotherapist to Improve the Collection of Radio-induced Toxicities in Patients Undergoing Proton TherapyActive, not recruitingNCT05404308Not applicable
- Post Market Clinical Follow-up of CODMAN CERTAS Programmable ValveActive, not recruitingNCT05397106
- E6201 and Dabrafenib for the Treatment of Central Nervous System Metastases From BRAF V600 Mutated Metastatic MelanomaTerminatedNCT05388877Phase 1
- Pyrotinib Combined With Capecitabine in HER-2 Positive Advanced Breast Cancer and Brain Metastases (Post-PERMEATE)Status unknownNCT05359120
- Utidelone Plus Bevacizumab for Advanced Breast Cancer With Brain MetastasesStatus unknownNCT05357417Phase 2
- The Effects of Spiritual Needs on Spiritual Well-Being in Patients With Brain Tumors: A Structural Equation Modeling ApproachWithdrawnNCT05356507
- IL-8 Receptor-modified CD70 CAR T Cell Therapy in CD70+ Adult GlioblastomaActive, not recruitingNCT05353530Phase 1
- Activated Autologous T Cells Against Glioma Cancer Stem Cell Antigens for Patients With Recurrent GlioblastomaWithdrawnNCT05341947Phase 1
- A Phase II Study of Pre-Op SRS Followed by Surgical Resection for Brain MetastasesActive, not recruitingNCT05341739Not applicable
- Stereotactic Radiosurgery and Immune Checkpoint Inhibitors With NovoTTF-200M for the Treatment of Melanoma Brain MetastasesTerminatedNCT05341349Phase 1
- The Effect of Home Care Planned According to Orem in Patients With Primary Brain Tumor and Their CaregiversCompletedNCT05328739Not applicable
- Lazertinib in Patients With NSCLC With Asymptomatic or Mild Symptomatic Brain Metastases After Failure of EGFR TKI.Status unknownNCT05326425Phase 2
- Secondary BRain Metastases Prevention After Isolated Intracranial Progression on Trastuzumab/Pertuzumab or T-DM1 in Patients With aDvanced Human Epidermal Growth Factor Receptor 2+ brEast Cancer With the Addition of TucatinibActive, not recruitingNCT05323955Phase 2
- A Study of How Proton Beam Radiotherapy (PBRT) Affects Brain Function and Quality of Life in Children and Young Adults Undergoing Treatment for a Brain TumorActive, not recruitingNCT05288439Not applicable
- Why Still in Neurosurgical Ward After Tumor Craniotomy?CompletedNCT05288088
- HyperArc Registry StudyCompletedNCT05270707
- Preop fSRS for Resectable Brain MetastasesActive, not recruitingNCT05267587Phase 2
- Diffusion-tensor Imaging in Brain Tumors EvaluationStatus unknownNCT05261724
- Phase 1/2 Study of Silevertinib (BDTX-1535) in Patients With Glioblastoma or Non-Small Cell Lung Cancer With EGFR MutationsActive, not recruitingNCT05256290Phase 1/2
- Combination Liposomal Irinotecan and Pembrolizumab For Triple-Negative Breast Cancer (TNBC) With Brain Metastases (BM)WithdrawnNCT05255666Phase 2
- CONVIVO System to Discriminate Healthy Tissues vs Tumor Tissues During Brain Tumor ResectionWithdrawnNCT05247749Not applicable
- (Concerto) Study of BLU-451 in Advanced Cancers With EGFR Exon 20 Insertion MutationsTerminatedNCT05241873Phase 1
- Tislelizumab Plus Chemotherapy as First-Line Treatment for Advanced Squamous NSCLC With Brain MetastasesStatus unknownNCT05207904Phase 2
- Musical Training Programme to Improve Neurocognitive Functioning of Children Surviving Brain TumoursCompletedNCT05202925Not applicable
- Effect of Sugammadex for Reversal of Rocuronium-induced Neuromuscular Block on Perioperative Management of Awake CraniotomyStatus unknownNCT05202899Phase 4
- BRIANSTORM - Early Identification of Patients With Brain MetastasesStatus unknownNCT05185557
- A Phase I/II Study of AMG 510 in Combination With MVASI in Patients With Advanced, Unresectable or Metastatic KRAS G12C Mutant NSCLC With Asymptomatic Brain MetastasisWithdrawnNCT05180422Phase 1/2
- Tempus Priority Study: A Pan-tumor Observational StudyActive, not recruitingNCT05179824
- Hippocampal-Sparing Stereotactic Radiosurgery Treatment of Brain Metastases Using CyberKnifeStatus unknownNCT05177185Phase 2
- Radiomic Analysis for Predicting Treatment Response and Clinical Outcomes in MalignanciesStatus unknownNCT05170087
- Magrolimab in Children and Adults With Recurrent or Progressive Malignant Brain TumorsCompletedNCT05169944Phase 1
- Study of TY-9591 in Patients With a Lung Cancer With Brain or Leptomeningeal Metastases With EGFR MutationCompletedNCT05146219Phase 2
- The Relationship of Anesthesia Method With Serum Lactate Level in CraniotomiesCompletedNCT05145049
- Low Dose Versus Standard Dose Dexamethasone for Reduction of Swelling in Patients with Primary or Metastatic Brain TumorsActive, not recruitingNCT05139043Phase 2
- The BurnAlong Pilot Study for Adolescent and Young Adult Cancer SurvivorsCompletedNCT05131815Not applicable
- Outcomes With Immune Checkpoint Inhibitor for Patients With Non-Small-Cell Lung Cancer and Stable Brain MetastasesCompletedNCT05129202
- Quantitative Assessment of Radiation-induced Neuroinflammation - A Proof of Principle StudyActive, not recruitingNCT05128903Phase 2
- Re-TREAT: Re-irradiation for Relapsed Brain MetastasesStatus unknownNCT05126875Not applicable
- A Phase 1a/1b Study to Determine the Recommended Phase 2 Dose, of Tepotinib in Participants With MET Alterations and Brain TumorsWithdrawnNCT05120960Phase 1
- Osimertinib Combined With Bevacizumab in Patients With Brain Metastasis Epidermal Growth Factor Receptor (EGFR) Mutation Positive Metastatic Non-Small Cell Lung CancerStatus unknownNCT05104281Phase 3
- Comparaison Between MRI Alone or Combined With Positron Emission Tomography for Brain Metastasis DiagnosisCompletedNCT05095766
- The Efficacy of HLX208 (BRAF V600E Inhibitor) for Refractory Primary Brain Tumors With BRAF Mutation After First-line TreatmentStatus unknownNCT05092802Phase 2
- MRI and Blood Biomarkers for the Prediction of Neurocognitive Decline Following Brain RadiationTerminatedNCT05087888
- IORT After Surgical Resection of Brain MetastasesStatus unknownNCT05084092Phase 2
- Visual Rehabilitation in Children With Homonymous Hemianopia: a Pilot Study on Virtual-reality StimulationCompletedNCT05065268Not applicable
- Brain Tumor Intraoperative Ultrasound DatabaseCompletedNCT05062772
- Dual Time Point FDG PET/MRI Scan in Improving the Imaging Cancer Patients With Brain MetastasesCompletedNCT05054998Phase 4
- Study of Laser Interstitial Thermal Therapy (LITT) Treatment Response Assessment With Fluciclovine PET MRWithdrawnNCT05054400Early Phase 1
- RAPid SimPLE Targeted Radiation Treatment for Brain MetastasesActive, not recruitingNCT05050929Phase 2
- Comprehensive Evaluation of Tumor Oxygenation, Metabolism and Blood Supply of High Grade Glioma and Cervical Cancers Using Dynamic FAZA PET and Multiparametric MRActive, not recruitingNCT05047913Early Phase 1
- Tolerability and Activity of Brivaracetam (BRV) in Patients With Diffuse GliomasTerminatedNCT05029960Early Phase 1
- Study of DSP-0390 in Patients With Recurrent High-Grade GliomaActive, not recruitingNCT05023551Early Phase 1
- Toripalimab Combined With Anlotinib and SBRT in Patients With Untreated Brain Metastases of Driven Gene-negative NSCLCCompletedNCT05021328Phase 1
- ARX788 in HER2-positive Breast Cancer Patients With Brain MetastasesStatus unknownNCT05018702Phase 2
- Nivolumab and Ipilimumab Plus Chemotherapy for Patients With Stage IV Lung Cancer With Brain MetastasesActive, not recruitingNCT05012254Phase 2
- Evaluate the Safety and Preliminary Efficacy of the Combination of NaviFUS System With Re-irradiation for rGBM PatientsCompletedNCT04988750Not applicable
- the Efficacy and Safety of Anlotinib Combined With Almonertinib in the First-line Treatment of Patients With Brain Metastases From EGFR Mutation-positive Non-small Cell Lung CancerStatus unknownNCT04978753Phase 2
- Educating Brain Tumor Patients Using Patient-specific Actual-size Three-dimensional Printed ModelsStatus unknownNCT04970615
- Phase 1 Trial for Tumor Treating Field for Drug/Radiation Resistant Brain MetastasesStatus unknownNCT04967027Early Phase 1
- MR-Linac Guided Adaptive FSRT for Brain Metastases From Non-small Cell Lung CancerCompletedNCT04946019Phase 2
- The Application of Glucose CEST MR Imaging in Brain TumorStatus unknownNCT04945499Early Phase 1
- 7T MRI Scan for the Early Detection of Melanoma Brain MetastasesTerminatedNCT04941430Not applicable
- BRAINFUL (BRAIN Tumor Focused Ultrasound-enabled Liquid Biopsy) TrialActive, not recruitingNCT04940507Not applicable